Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often highlight the possibility for meaningful therapeutic outcomes, principally in conditions where conventional treatments have proven ineffective. However, crucially important to consider the considerable financial burden associated